Skip to main navigation Skip to search Skip to main content

Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC: The authors reply

Research output: Contribution to journal › Letter › peer-review

Original languageEnglish
Pages (from-to)620-621
Number of pages2
JournalNew England Journal of Medicine
Volume392
Issue number6
DOIs
Publication statusPublished - 2025 Feb 6

All Science Journal Classification (ASJC) codes

  • General Medicine

Cite this